Seung-Yong Hwang
Chief Tech/Sci/R&D Officer chez INVITES BIOCORE CO., LTD.
Profil
Seung-Yong Hwang is currently the Vice Chairman & Chief Technology Officer at Invites Biocore Co., Ltd.
since 2014.
He is also a Professor at Hanyang University since 1997.
Previously, he served as the Chief Executive Officer at GenoCheck Co., Ltd.
and held positions as Chairman-Education & Publication Committee at Korea Biochip Society and The Korean Society of Toxicogenomics & Toxicoproteomics.
Dr. Hwang obtained his doctorate degree from Monash University in 1997.
Postes actifs de Seung-Yong Hwang
Sociétés | Poste | Début |
---|---|---|
INVITES BIOCORE CO., LTD. | Chief Tech/Sci/R&D Officer | 01/12/2014 |
Hanyang University | Corporate Officer/Principal | 01/09/1997 |
Anciens postes connus de Seung-Yong Hwang
Sociétés | Poste | Fin |
---|---|---|
Korea Biochip Society | Corporate Officer/Principal | - |
The Korean Society of Toxicogenomics & Toxicoproteomics | Corporate Officer/Principal | - |
GenoCheck Co., Ltd.
GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Chief Executive Officer | - |
Formation de Seung-Yong Hwang
Monash University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
INVITES BIOCORE CO., LTD. | Commercial Services |
Entreprise privées | 3 |
---|---|
GenoCheck Co., Ltd.
GenoCheck Co., Ltd. Medical SpecialtiesHealth Technology GenoCheck Co., Ltd. is a holding company, which conducts research in biotechnology and offers products and services related to genes. Its activities include exploring and testing of genes related to human diseases, developing diagnostic deoxyribonucleic acid (DNA) chip and new drugs. The firm's products include microarray, ribonucleic acid stabilization solution, and DNA extraction kit. The company was founded on May 1, 2000 and is headquartered in Seoul, South Korea. | Health Technology |
Korea Biochip Society | |
The Korean Society of Toxicogenomics & Toxicoproteomics |